Asia Breast Cancer Screening Industry is expected to expand at a CAGR of 8.5% during 2021-2027:
The major driving forces for expanding the breast cancer screening market in Asia are increasing breast cancer awareness, government and NGOs supporting breast cancer screening programs, and the aging population.
Nevertheless, critical threats for the breast cancer screening market in Asia are societal fear, misconceptions, and cultural barriers. Another major challenge being faced by almost all Asian countries is the non-availability of national-level screening programs; however, partial or regional screening programs are available in a few of Asian countries.
Mammogram Screening Leads Breast Cancer Screening in Asia:
Our report studies Breast Cancer Screening in Asia through Mammography Screening, MRI Screening, and Ultrasound Screening. As per our analysis, the mammogram is the leading method for breast cancer screening in Asian countries. Further, we have also made the market estimation that China, Japan, and Korea are the top three countries for breast cancer mammogram screening. Other Asian countries included in our study are India, Singapore, Malaysia, and Thailand for breast cancer mammogram screening.
China Holds Significant Dominance in Asia Breast Cancer Screening Market:
Our report studies the breast cancer screening market of Asian countries like India, China, Japan, Korea, Singapore, Thailand, and Malaysia. As per our analysis, China, Japan, and Korea are the top-most contributors to the breast cancer screening industry. In addition, China holds significant dominance in the Asia breast cancer screening market. Further, a prominent women population and domestic NGOs initiatives support China to become a leader in the Asian breast cancer screening market.
COVID-19 Impact on the Asia Breast Cancer Screening Industry:
Globally, over a billion people had been affected due to novel Coronavirus for the first time in 2020. The whole world had been facing problems in healthcare and the financial world during the pandemic era. Besides, most healthcare centers had reserved their team and resources for the treatment of COVID-19 patients, and due to this outbreak, women avoided diagnostics centers as lockdowns were imposed by governments across the world, declining the market. As per The report, Asia Breast Cancer Screening Market Size was USD 10.1 Billion in 2021 post recovery from the pandemic.
Key Players:
The companies contributing to the growth of the Asia breast cancer screening market include AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Sun Pharmaceutical Industries Ltd. The market players are considerably contributing to market growth by adopting various strategies, including new product launches, mergers and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market.
This study titled Asia Breast Cancer Screening Market Forecast By Population Analysis (Mammography, MRI & Ultrasound),Market Analysis (Mammography Screening Market, MRI Screening Market, Ultrasound Screening Market), Countries (India, China, Japan, Korea, Singapore, Thailand and Malaysia), Company (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Sun Pharmaceutical Industries Ltd.) provides a detailed analysis of Asia Breast Cancer Screening Industry.
Asia Breast Cancer Screening Population Analysis has been covered from 2 viewpoints:
1. Mammography Screening Population
2. MRI & Ultrasound Screening Population
Asia Breast Cancer Screening Market Analysis has been covered from 3 viewpoints:
1. Mammography Screening Market
2. MRI Screening Market
3. Ultrasound Screening Market
Countries covered in Asia Breast Cancer Screening Market Analysis have been covered from 7 viewpoints:
1. India
2. China
3. Japan
4. Korea
5. Singapore
6. Thailand
7. Malaysia
Company Insights:
- Overview
- Recent Development
- Revenue
Company Analysis:
1. AstraZeneca
2. Novartis
3. Sanofi
4. Pfizer
5. Bayer AG
6. GlaxoSmithKline plc
7. Hoffmann-La Roche Ltd.
8. Sun Pharmaceutical Industries Ltd
What is the estimated value of the Asia Breast Cancer Screening Market?
What is the growth rate of the Asia Breast Cancer Screening Market?
What is the forecasted size of the Asia Breast Cancer Screening Market?
Who are the key companies in the Asia Breast Cancer Screening Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 240 |
| Published | March 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 10.1 Billion |
| Forecasted Market Value ( USD | $ 16.5 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 8 |
Table of Contents
Companies Mentioned
- AstraZeneca
- Novartis
- Sanofi
- Pfizer
- Bayer AG
- GlaxoSmithKline plc
- Hoffmann-La Roche Ltd.
- Sun Pharmaceutical Industries Ltd
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
